|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits with other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Debt securities available for sale (at fair value) | ||||||||||||||||||||
| Debt securities held to maturity (at amortized cost; estimated fair value - $87,029 - 2024, $88,319 - 2023) | ||||||||||||||||||||
| Less: allowance for credit losses | ||||||||||||||||||||
| Debt securities held to maturity, net | ||||||||||||||||||||
| Equity investments (at fair value) | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans net of unearned fees | ||||||||||||||||||||
| Loans, net of unearned fees | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Property held for sale | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest and fees receivable | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Cash surrender value of life insurance policies and annuities | ||||||||||||||||||||
| Derivative financial instruments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Subordinated debentures, net | ||||||||||||||||||||
| Subordinated debentures owed to unconsolidated subsidiary trusts | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred Stock, Shares Authorized | ||||||||||||||||||||
| Common stock, shares outstanding | ||||||||||||||||||||
| Employee Stock Ownership Plan (ESOP), Number of Suspense Shares | ||||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, shares authorized | ||||||||||||||||||||
| Common stock, shares issued | ||||||||||||||||||||
| Preferred Stock, Shares Issued | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Preferred stock and related surplus, $1.00 par value, authorized 250,000 shares; issued: 2024 and 2023 - 1,500 shares | ||||||||||||||||||||
| Common stock and related surplus, $2.50 par value; authorized 20,000,000 shares; issued and outstanding: 2024 - 14,686,738 shares and 2023 - 14,683,457 shares | ||||||||||||||||||||
| Unallocated common stock held by Employee Stock Ownership Plan - 2022 - 10,351 shares and 2021 - 20,702 shares | ||||||||||||||||||||
| Unallocated common stock held by Employee Stock Ownership Plan - 2022 - 5,175 shares and 2021 - 20,702 shares | ||||||||||||||||||||
| Unallocated common stock held by Employee Stock Ownership Plan - 2021 - 20,702 shares | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
| Debt Securities, Held-to-maturity, Fair Value |
Loading...
